Skip to main content
Journal of Translational Medicine logoLink to Journal of Translational Medicine
. 2024 May 3;22:420. doi: 10.1186/s12967-024-05161-3

Correction to: Role of Hippo pathway dysregulation from gastrointestinal premalignant lesions to cancer

Giulia Schiavoni 1, Beatrice Messina 1, Stefano Scalera 2, Lorenzo Memeo 3, Cristina Colarossi 3, Marzia Mare 4,5, Giovanni Blandino 6, Gennaro Ciliberto 7, Giulia Bon 8,✉, Marcello Maugeri-Saccà 1,9
PMCID: PMC11067124  PMID: 38702720

Correction to: Journal of Translational Medicine (2024) 22:213

10.1186/s12967-024-05027-8

Following publication of the original article [1], we have been notified that the Funding note was published incorrectly.

It is now:

Dr. Maugeri-Saccà is supported by the Italian Association for Cancer Research (AIRC) under MFAG 2019 (project identification: 22940) and the Italian Ministry of Health (MoH) (project identification: GR-2016?02362025).

It should be:

This work was financially supported through funding from the institutional “Ricerca Corrente” granted by the Italian Ministry of Health.

Footnotes

The online version of the original article can be found at 10.1186/s12967-024-05027-8.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Schiavoni et al. (2024) Role of Hippo pathway dysregulation from gastrointestinal premalignant lesions to cancer (2024). 22:213 10.1186/s12967-024-05027-8. [DOI] [PMC free article] [PubMed]

Articles from Journal of Translational Medicine are provided here courtesy of BMC

RESOURCES